Golden Gate Capital, a private equity investment firm with more than $12 billion of committed capital under management, today announced that investment funds managed by Golden Gate Capital have successfully completed the acquisition of Angus Chemical Company (Angus), the world’s only chemical company dedicated to the manufacture and distribution of nitroalkanes and their derivatives, from The Dow Chemical Company DOW, +2.41%.

Angus will continue to be led by its current senior management team, including President and CEO Mark A. Henning. Additionally, Angus will continue to honor all customer, licensing and supplier contracts and related agreements.

“We strongly support Angus management and believe their strategic vision for the Company will drive long-term success,” said Rajeev Amara, Managing Director at Golden Gate Capital. “Looking ahead, we are focused on working with the ANGUS team to invest in targeted growth areas through their Customer Application Centers as well as in their people, capacity, and next generation R&D pipeline.”

“While our ownership has changed, our commitment to our customers remains stronger than ever,” said Mark A. Henning, Angus President and CEO. “We look forward to working with our new partners to continue our positive momentum in the marketplace – driving growth at the local level by constantly proving how ANGUS chemistry helps our customers’ products and processes perform better.”

As previously announced, the $1.215 billion transaction includes the ANGUS business headquarters and R&D facility in Buffalo Grove, IL; manufacturing facilities located in Sterlington, LA, and Ibbenbueren, Germany; a life-science additive facility in Niagara Falls, NY; as well as the associated business, inventory, customer contracts, process technology, business know-how and certain intellectual property.